Cagrilintide
Long-acting amylin receptor agonist researched for appetite regulation and satiety.
Recon & Dosing
Open the calculator for Cagrilintide vials.
- Category
- Metabolic / GLP-1
- Half-life
- ~7 days
- Typical vial
- 5 mg lyophilised
- Reported research dose
- 0.3–4.5 mg weekly in trial arms
Mechanism of action
Amylin analogue acting on hindbrain satiety circuits; frequently studied alongside GLP-1s.
Storage & handling
Refrigerate before and after reconstitution.
Run the reconstitution math →Research notes
- Studied in combination protocols under the CagriSema designation.
Research use only. Figures above summarise published literature and community protocols for reference. Nothing here is a recommendation for human use.